Negócios · 31/03/20051 min de leitura
Cardiovascular and Renal Drugs Advisory Committee; Cancellation
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is canceling the meeting of the Cardiovascular and Renal Drugs Advisory Committee scheduled for April 5, 2005. This meeting was announced in the Federal Register of March 9, 2005 (70 FR 11678).